The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications

Thematic sections

Thematic Section Chairperson 1 Introduction F. Piscaglia – C. Nolsøe 2 Generalities D. Cosgrove 3 Equipment H. P. Weskott 4 Investigator’s training O. H. Gilja 5 Terminology F. Piscaglia 6 Safety G. ter Haar 7 Paediatric C. Nolsøe 8 Pancreas M. D’Onofrio 9 Endoscopic CEUS C. F. Dietrich 10 Gastrointestinal tract O. H. Gilja 11 Spleen O. Catalano 12 Kidney M. Bertolotto 13 Vesicoureteral reflux M. Bertolotto 14 Scrotum P. S. Sidhu 15 Abdominal Trauma O. Catalano 16 Lung and pleural lesions G. Mathis 17 Vascular D. Clevert 18 Cerebral vessels G. Seidel 19 Inflammatory joint diseases A. S. Klauser 20 Intracavitary A. Ignee 21 Lymphnodes M. Hocke 22 Tumour response assessment E. Leen 23 Breast D. Cosgrove 24 Adrenals H. P. Weskott 25 Emerging CEUS applications and future perspectives A Gynecology D. Timmerman B Perineum C. F. Dietrich C Urinary Bladder F. M. Drudi D Transplanted Kidney M. Bertolotto E Prostate Cancer J. M. Correas F Aorto-caval fistula D. Clevert G Free Tissue Transplants E. M. Jung H Extrahepatic Biliary System C. F. Dietrich 26 Use of CEUS in patients with renal failure J. M. Correas – T. Albrecht 27 Technical Appendix F. Piscaglia – C. Nolsøe

References

• 1 Bertolotto M, Dalla P alma L, Quaia E et al. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.  Eur Radiol. 2000;  10 1369-1376
• 2 Burns P N, Wilson S R, Simpson D H. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast.  Invest Radiol. 2000;  35 58-71
• 3 Albrecht T, Blomley M, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. January 2004.  Ultraschall in Med. 2004;  25 249-256
• 4 Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008.  Ultraschall in Med. 2008;  29 28-44
• 5 Nolsoe C, Piscaglia F, Dietrich C F et al. Reply to M. Piskunowicz, W. Kosiak and N. Irga’s Letter to the Editor entitled “Primum non nocere? Why Can’t We Use Second Generation Ultrasound Contrast Agents for the Examination of Children?”.  Ultraschall in Med. 2011;  32 83-86
• 6 Averkiou M, Powers J, Skyba D et al. Ultrasound contrast imaging research.  Ultrasound Q. 2003;  19 27-37
• 7 Schrope B A, Newhouse V L. Second harmonic ultrasonic blood perfusion measurement.  Ultrasound Med Biol. 1993;  19 567-579
• 8 Simpson D H, Chin C T, Burns P N. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents.  IEEE Trans Ultrason Ferroelectr Freq Control. 1999;  46 372-382
• 9 Burns P, Powers J, Hope Simpson D et al. Harmonic Imaging: principals and preliminary results.  Angiology. 1996;  47 SA63-SA74
• 10 Dietrich C F, Ignee A, Hocke M et al. Pitfalls and artefacts using contrast enhanced ultrasound.  Z Gastroenterol. 2011;  49 350-356
• 11 Minimum training recommendations for the practice of medical ultrasound.  Ultraschall in Med. 2006;  27 79-105
• 12 Minimum training requirements for the practice of Medical Ultrasound in Europe.  Ultraschall in Med. 2010;  31 426-427
• 13 Gilja O H. Report Education and Professional Standard Commitee. In EFSUMB Newsletter.  Ultraschall in Med. 2009;  30 86-87
• 14 Lassau N, Chami L, Benatsou B et al. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment.  Eur Radiol. 2007;  17 (Suppl 6) F89-F98
• 15 Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23 188 investigations.  Ultrasound Med Biol. 2006;  32 1369-1375
• 16 ter Haar G. Safety and bio-effects of ultrasound contrast agents.  Med Biol Eng Comput. 2009;  47 893-900
• 17 Blomley M, Claudon M, Cosgrove D. WFUMB Safety Symposium on Ultrasound Contrast Agents: clinical applications and safety concerns.  Ultrasound Med Biol. 2007;  33 180-186
• 18 Barnett S B. Safe use of ultrasound contrast agents.  Ultrasound Med Biol. 2007;  33 171-172
• 19 Main M L, Goldman J H, Grayburn P A. Ultrasound contrast agents: balancing safety versus efficacy.  Expert Opin Drug Saf. 2009;  8 49-56
• 20 Main M L, Ryan A C, Davis T E et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).  Am J Cardiol. 2008;  102 1742-1746
• 21 Dietrich C F, Braden B, Hocke M et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound.  J Cancer Res Clin Oncol. 2008;  134 635-643
• 22 D’Onofrio M, Megibow A J, Faccioli N et al. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses.  Am J Roentgenol. 2007;  189 1435-1442
• 23 Kitano M, Kudo M, Maekawa K et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography.  Gut. 2004;  53 854-859
• 24 D’Onofrio M, Malago R, Zamboni G et al. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT.  Pancreatology. 2005;  5 398-402
• 25 Faccioli N, D’Onofrio M, Malago R et al. Resectable pancreatic adenocarcinoma: depiction of tumoral margins at contrast-enhanced ultrasonography.  Pancreas. 2008;  37 265-268
• 26 Grossjohann H S, Rappeport E D, Jensen C et al. Usefulness of contrast-enhanced transabdominal ultrasound for tumor classification and tumor staging in the pancreatic head.  Scand J Gastroenterol. 2010;  45 917-924
• 27 D’Onofrio M, Zamboni G, Tognolini A et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography.  World J Gastroenterol. 2006;  12 4181-4184
• 28 Kersting S, Konopke R, Kersting F et al. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas.  Gastroenterology. 2009;  137 1903-1911
• 29 Numata K, Ozawa Y, Kobayashi N et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings.  J Gastroenterol. 2005;  40 631-640
• 30 D’Onofrio M, Barbi E, Dietrich C F. Pancreatic multicenter ultrasound study (PAMUS).  Eur J Radiol 2011. e-pub DOI: 10.1016/j.ejrad.2011.1001.1053
• 31 Tawada K, Yamaguchi T, Kobayashi A et al. Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer.  Pancreas. 2009;  38 30-35
• 32 Kobayashi A, Yamaguchi T, Ishihara T et al. Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy.  Gut. 2005;  54 1047
• 33 D’Onofrio M, Mansueto G, Falconi M et al. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography.  Abdom Imaging. 2004;  29 246-258
• 34 Malago R, D’Onofrio M, Zamboni G A et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors.  Am J Roentgenol. 2009;  192 424-430
• 35 Rickes S, Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound.  J Gastroenterol Hepatol. 2004;  19 761-766
• 36 Itoh T, Hirooka Y, Itoh A et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas.  Am J Gastroenterol. 2005;  100 144-152
• 37 Dietrich C F, Ignee A, Braden B et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound.  Clin Gastroenterol Hepatol. 2008;  6 590-597, e591
• 38 D’Onofrio M, Gallotti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors.  Expert Rev Med Devices. 2010;  7 257-273
• 39 Ripolles T, Martinez M J, Lopez E et al. Contrast-enhanced ultrasound in the staging of acute pancreatitis.  Eur Radiol. 2010;  20 2518-2523
• 40 Becker D, Strobel D, Bernatik T et al. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma.  Gastrointest Endosc. 2001;  53 784-789
• 41 Bhutani M S, Hoffman B J, Velse van A et al. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508 A (Levovist).  Endoscopy. 1997;  29 635-639
• 42 Dietrich C F, Ignee A, Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique.  Z Gastroenterol. 2005;  43 1219-1223
• 43 Dietrich C F. Contrast-enhanced low mechanical index endoscopic ultrasound (CELMI-EUS).  Endoscopy. 2009;  41 (Suppl 2) E43-E44
• 44 Kitano M, Sakamoto H, Matsui U et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video).  Gastrointest Endosc. 2008;  67 141-150
• 45 Hocke M, Schmidt C, Zimmer B et al. [Contrast enhanced endosonography for improving differential diagnosis between chronic pancreatitis and pancreatic cancer].  Dtsch Med Wochenschr. 2008;  133 1888-1892
• 46 Hocke M, Schulze E, Gottschalk P et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer.  World J Gastroenterol. 2006;  12 246-250
• 47 Kitano M, Takagi T, Sakamoto H. Dynamic imaging of pancreatic tumors by contrast-enhanced harmonic EUS with long-lasting contrast.  Gastrointestinal Endoscopy. 2009;  67 141-150
• 48 Sakamoto H, Kitano M, Kamata K et al. Diagnosis of pancreatic tumors by endoscopic ultrasonography.  World J Radiol. 2010;  2 122-134
• 49 Hirooka Y, Itoh A, Kawashima H et al. Diagnosis of pancreatic disorders using contrast-enhanced endoscopic ultrasonography and endoscopic elastography.  Clin Gastroenterol Hepatol. 2009;  7 S63-S67
• 50 Saftoiu A, Iordache S A, Gheonea D I et al. Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos).  Gastrointest Endosc. 2010;  72 739-747
• 51 Giovannini M. Contrast-enhanced endoscopic ultrasound and elastosonoendoscopy.  Best Pract Res Clin Gastroenterol. 2009;  23 767-779
• 52 Hocke M, Ignee A, Topalidis T et al. Contrast-enhanced endosonographic Doppler spectrum analysis is helpful in discrimination between focal chronic pancreatitis and pancreatic cancer.  Pancreas. 2007;  35 286-288
• 53 Napoleon B, Alvarez-Sanchez M V, Gincoul R et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study.  Endoscopy. 2010;  42 564-570
• 54 Seicean A, Badea R, Stan-Iuga R et al. The added value of real-time harmonics contrast-enhanced endoscopic ultrasonography for the characterisation of pancreatic diseases in routine practice.  J Gastrointestin Liver Dis. 2010;  19 99-104
• 55 Seicean A, Badea R, Stan-Iuga R et al. Quantitative contrast-enhanced harmonic endoscopic ultrasonography for the discrimination of solid pancreatic masses.  Ultraschall in Med. 2010;  31 571-576
• 56 Fusaroli P, Spada A, Mancino M G et al. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses.  Clin Gastroenterol Hepatol. 2010;  8 629-634, e621 – e622
• 57 Beyer-Enke S A, Hocke M, Ignee A et al. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance.  JOP. 2010;  11 427-433
• 58 Hocke M, Ignee A, Dietrich C F. Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis.  Endoscopy. 2011;  43 163-165
• 59 Plikat K, Klebl F, Buchner C et al. [Evaluation of intestinal hyperaemia in inflamed bowel by high resolution Contrast Harmonic Imaging (CHI)].  Ultraschall in Med. 2004;  25 257-262
• 60 Girlich C, Jung E M, Iesalnieks I et al. Quantitative assessment of bowel wall vascularisation in Crohn’s disease with contrast-enhanced ultrasound and perfusion analysis.  Clin Hemorheol Microcirc. 2009;  43 141-148
• 61 Schlottmann K, Kratzer W, Scholmerich J. Doppler ultrasound and intravenous contrast agents in gastrointestinal tract disorders: current role and future implications.  Eur J Gastroenterol Hepatol. 2005;  17 263-275
• 62 Schreyer A G, Finkenzeller T, Gossmann H et al. Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn’s disease: first results with linear contrast harmonic imaging (CHI).  Clin Hemorheol Microcirc. 2008;  40 143-155
• 63 Pauls S, Gabelmann A, Schmidt S A et al. Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound.  Eur Radiol. 2006;  16 2410-2417
• 64 Haber H P, Busch A, Ziebach R et al. Bowel wall thickness measured by ultrasound as a marker of Crohn’s disease activity in children.  Lancet. 2000;  355 1239-1240
• 65 Maconi G, Parente F, Bollani S et al. Abdominal ultrasound in the assessment of extent and activity of Crohn’s disease: clinical significance and implication of bowel wall thickening.  Am J Gastroenterol. 1996;  91 1604-1609
• 66 Spalinger J, Patriquin H, Miron M C et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity.  Radiology. 2000;  217 787-791
• 67 Robotti D, Cammarota T, Debani P et al. Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography.  Abdom Imaging. 2004;  29 648-652
• 68 De Pascale A, Garofalo G, Perna M et al. Contrast-enhanced ultrasonography in Crohn’s disease.  Radiol Med. 2006;  111 539-550
• 69 Serra C, Menozzi G, Labate A M et al. Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn’s disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent.  Eur J Radiol. 2007;  62 114-121
• 70 Migaleddu V, Scanu A M, Quaia E et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease.  Gastroenterology. 2009;  137 43-52
• 71 Girlich C, Schacherer D, Jung E M et al. Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn’s disease.  Eur J Radiol. 2011;  epub DOI: 10.1016/j.ejrad.2011.02.054
• 72 Ripolles T, Martinez M J, Paredes J M et al. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy.  Radiology. 2009;  253 241-248
• 73 Guidi L, De Franco A, De Vitis I et al. Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn’s disease.  Eur Rev Med Pharmacol Sci. 2006;  10 23-26
• 74 Kratzer W, Tirpitz von C, Mason R et al. Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn’s disease.  J Ultrasound Med. 2002;  21 149-157, quiz 158 – 149
• 75 Wilson S R, Burns P N. Microbubble-enhanced US in body imaging: what role?.  Radiology. 2010;  257 24-39
• 76 Girlich C, Schacherer D, Lamby P et al. Innovations in contrast enhanced high resolution ultrasound improve sonographic imaging of the intestine.  Clin Hemorheol Microcirc. 2010;  45 207-215
• 77 Henrich W, Meckies J, Friedmann W. Demonstration of a recto-vaginal fistula with the ultrasound contrast medium Echovist.  Ultrasound Obstet Gynecol. 2000;  15 148-149
• 78 Dietrich C F. Significance of abdominal ultrasound in inflammatory bowel disease.  Dig Dis. 2009;  27 482-493
• 79 Gorg C, Bert T. Contrast enhanced sonography of focal splenic lesions with a second-generation contrast agent.  Ultraschall in Med. 2005;  26 470-477
• 80 Cavalli G, Re G, Casali A M. Red pulp arterial terminals in congestive splenomegaly. A morphometric study.  Pathol Res Pract. 1984;  178 590-594
• 81 Lim A K, Patel N, Eckersley R J et al. Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers.  Radiology. 2004;  231 785-788
• 82 Bertolotto M, Quaia E, Zappetti R et al. Differential diagnosis between splenic nodules and peritoneal metastases with contrast-enhanced ultrasound based on signal-intensity characteristics during the late phase.  Radiol Med. 2009;  114 42-51
• 83 Gorg C, Bert T. Second-generation sonographic contrast agent for differential diagnosis of perisplenic lesions.  Am J Roentgenol. 2006;  186 621-626
• 84 Gorg C, Graef C, Bert T. Contrast-enhanced sonography for differential diagnosis of an inhomogeneous spleen of unknown cause in patients with pain in the left upper quadrant.  J Ultrasound Med. 2006;  25 729-734
• 85 Liu G J, Lu M D, Xie X Y et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions.  J Ultrasound Med. 2008;  27 657-666
• 86 Chiavaroli R, Grima P, Tundo P. Characterization of nontraumatic focal splenic lesions using contrast-enhanced sonography.  J Clin Ultrasound. 2011;  39 310-315
• 87 Catalano O, Sandomenico F, Matarazzo I et al. Contrast-enhanced sonography of the spleen.  Am J Roentgenol. 2005;  184 1150-1156
• 88 Gorg C, Faoro C, Bert T et al. Contrast enhanced ultrasound of splenic lymphoma involvement.  Eur J Radiol. 2009;  epub DOI: 10.1016/j.ejrad.2009.11.012
• 89 Sutherland T, Temple F, Hennessy O et al. Contrast-enhanced ultrasound features of primary splenic lymphoma.  J Clin Ultrasound. 2010;  38 317-319
• 90 Yu X, Yu J, Liang P et al. Real-time contrast-enhanced ultrasound in diagnosing of focal spleen lesions.  Eur J Radiol. 2011;  epub DOI: 10.1016/j.ejrad.2010.12.052
• 91 Herbay von A, Barreiros A P, Ignee A et al. Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen.  J Ultrasound Med. 2009;  28 421-434
• 92 Stang A, Keles H, Hentschke S et al. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography.  Am J Roentgenol. 2009;  193 709-721
• 93 Tafuto S, Catalano O, Barba G et al. Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lymphomas.  Front Biosci. 2006;  11 2224-2229
• 94 Neesse A, Huth J, Kunsch S et al. Contrast-enhanced ultrasound pattern of splenic metastases – a retrospective study in 32 patients.  Ultraschall in Med. 2010;  31 264-269
• 95 Picardi M, Soricelli A, Pane F et al. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study.  Radiology. 2009;  251 574-582
• 96 Correas J M, Claudon M, Tranquart F et al. The kidney: imaging with microbubble contrast agents.  Ultrasound Q. 2006;  22 53-66
• 97 Bertolotto M, Martegani A, Aiani L et al. Value of contrast-enhanced ultrasonography for detecting renal infarcts proven by contrast enhanced CT. A feasibility study.  Eur Radiol. 2008;  18 376-383
• 98 Bertolotto M, Catalano O. Contrast-enhanced Ultrasound: Past, Present, and Future. in: Advances in Ultrasound, An Issue of Ultrasound Clinics.  Elsevier Science. 2009;  4 339-367
• 99 Blebea J, Zickler R, Volteas N et al. Duplex imaging of the renal arteries with contrast enhancement.  Vasc Endovascular Surg. 2003;  37 429-436
• 100 Tamai H, Takiguchi Y, Oka M et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors.  J Ultrasound Med. 2005;  24 1635-1640
• 101 Mazziotti S, Zimbaro F, Pandolfo A et al. Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors.  Abdom Imaging. 2010;  35 241-245
• 102 Ignee A, Straub B, Brix D et al. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses.  Clin Hemorheol Microcirc. 2010;  46 275-290
• 103 Quaia E, Bertolotto M, Cioffi V et al. Comparison of contrast-enhanced sonography with unenhanced sonography and contrast-enhanced CT in the diagnosis of malignancy in complex cystic renal masses.  Am J Roentgenol. 2008;  191 1239-1249
• 104 Clevert D A, Minaifar N, Weckbach S et al. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system.  Clin Hemorheol Microcirc. 2008;  39 171-178
• 105 Park B K, Kim B, Kim S H et al. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US.  Eur J Radiol. 2007;  61 310-314
• 106 Ascenti G, Mazziotti S, Zimbaro G et al. Complex cystic renal masses: characterization with contrast-enhanced US.  Radiology. 2007;  243 158-165
• 107 Ignee A, Straub B, Schuessler G et al. Contrast enhanced ultrasound of renal masses.  World J Radiol. 2010;  2 15-31
• 108 Wink M H, Lagerveld B W, Laguna M P et al. Cryotherapy for renal-cell cancer: diagnosis, treatment, and contrast-enhanced ultrasonography for follow-up.  J Endourol. 2006;  20 456-458, discussion 458 – 459
• 109 Johnson D B, Duchene D A, Taylor G D et al. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion.  J Endourol. 2005;  19 248-252
• 110 Hoeffel C, Pousset M, Timsit M O et al. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour.  Eur Radiol. 2010;  20 1812-1821
• 111 Meloni M F, Bertolotto M, Alberzoni C et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.  Am J Roentgenol. 2008;  191 1233-1238
• 112 Darge K. Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure.  Pediatr Radiol. 2008;  38 40-53
• 113 Darge K. Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children. II. Comparison with radiological examinations.  Pediatr Radiol. 2008;  38 54-63, quiz 126 – 127
• 114 Darge K. Voiding urosonography with US contrast agent for the diagnosis of vesicoureteric reflux in children: an update.  Pediatr Radiol. 2010;  40 956-962
• 115 Ascenti G, Zimbaro G, Mazziotti S et al. Harmonic US imaging of vesicoureteric reflux in children: usefulness of a second generation US contrast agent.  Pediatr Radiol. 2004;  34 481-487
• 116 Lebowitz R L, Olbing H, Parkkulainen K V et al. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children.  Pediatr Radiol. 1985;  15 105-109
• 117 Duran C, Valera A, Alguersuari A et al. Voiding urosonography: the study of the urethra is no longer a limitation of the technique.  Pediatr Radiol. 2009;  39 124-131
• 118 Moschouris H, Stamatiou K, Lampropoulou E et al. Imaging of the acute scrotum: is there a place for contrast-enhanced ultrasonography?.  Int Braz J Urol. 2009;  35 692-702, discussion 702 – 695
• 119 Bilagi P, Sriprasad S, Clarke J L et al. Clinical and ultrasound features of segmental testicular infarction: six-year experience from a single centre.  Eur Radiol. 2007;  17 2810-2818
• 120 Sriprasad S, Kooiman G G, Muir G H et al. Acute segmental testicular infarction: differentiation from tumour using high frequency colour Doppler ultrasound.  Br J Radiol. 2001;  74 965-967
• 121 Bertolotto M, Derchi L E, Sidhu P S et al. Acute segmental testicular infarction at contrast-enhanced ultrasound: early features and changes during follow-up.  Am J Roentgenol. 2011;  196 834-841
• 122 Valentino M, Bertolotto M, Derchi L et al. Role of contrast enhanced ultrasound in acute scrotal diseases.  Eur Radiol. 2011;  epub DOI: 10.1007/s00330-010-2039-5
• 123 Bhatt S, Rubens D J, Dogra V S. Sonography of benign intrascrotal lesions.  Ultrasound Q. 2006;  22 121-136
• 124 Winter T C. There is a mass in the scrotum-what does it mean? Evaluation of the scrotal mass.  Ultrasound Q. 2009;  25 195-205
• 125 Lock G, Schmidt C, Helmich F et al. Early Experience With Contrast-enhanced Ultrasound in the Diagnosis of Testicular Masses: A Feasibility Study.  Urology. 2011;  77 1049-1053
• 126 Shah A, Lung P F, Clarke J L et al. Re: New ultrasound techniques for imaging of the indeterminate testicular lesion may avoid surgery completely.  Clin Radiol. 2010;  65 496-497
• 127 Catalano O, Lobianco R, Sandomenico F et al. Splenic trauma: evaluation with contrast-specific sonography and a second-generation contrast medium: preliminary experience.  J Ultrasound Med. 2003;  22 467-477
• 128 Valentino M, Serra C, Zironi G et al. Blunt abdominal trauma: emergency contrast-enhanced sonography for detection of solid organ injuries.  Am J Roentgenol. 2006;  186 1361-1367
• 129 Catalano O, Aiani L, Barozzi L et al. CEUS in abdominal trauma: multi-center study.  Abdom Imaging. 2009;  34 225-234
• 130 Reissig A, Gorg C, Mathis G. Transthoracic sonography in the diagnosis of pulmonary diseases: a systematic approach.  Ultraschall in Med. 2009;  30 438-454, quiz 455 – 436
• 131 Gorg C. Transcutaneous contrast-enhanced sonography of pleural-based pulmonary lesions.  Eur J Radiol. 2007;  64 213-221
• 132 Bertolini F A, Goerg C, Mathis G. Echo contrast ultrasound in subpleural consolidations.  Echo contrast ultrasound in subpleural consolidations. 2008;  18 (Suppl S 395) Abstract
• 133 Gorg C, Bert T, Gorg K. Contrast-enhanced sonography for differential diagnosis of pleurisy and focal pleural lesions of unknown cause.  Chest. 2005;  128 3894-3899
• 134 Gorg C, Bert T, Kring R et al. Transcutaneous contrast enhanced sonography of the chest for evaluation of pleural based pulmonary lesions: experience in 137 patients.  Ultraschall in Med. 2006;  27 437-444
• 135 Clevert D A, Johnson T, Michaely H et al. High-grade stenoses of the internal carotid artery: comparison of high-resolution contrast enhanced 3D MRA, duplex sonography and power Doppler imaging.  Eur J Radiol. 2006;  60 379-386
• 136 Jung E M, Kubale R, Ritter G et al. Diagnostics and characterisation of preocclusive stenoses and occlusions of the internal carotid artery with B-flow.  Eur Radiol. 2007;  17 439-447
• 137 Clevert D A, Johnson T, Jung E M et al. Color Doppler, power Doppler and B-flow ultrasound in the assessment of ICA stenosis: Comparison with 64-MD-CT angiography.  Eur Radiol. 2007;  17 2149-2159
• 138 Wechsler L R. Ulceration and carotid artery disease.  Stroke. 1988;  19 650-653
• 139 Clevert D A, Horng A, Jung E M et al. Contrast-enhanced ultrasound versus conventional ultrasound and MS-CT in the diagnosis of abdominal aortic dissection.  Clin Hemorheol Microcirc. 2009;  43 129-139
• 140 Clevert D A, Sommer W H, Zengel P et al. Imaging of carotid arterial diseases with contrast-enhanced ultrasound (CEUS).  Eur J Radiol. 2011;  epub DOI: 10.1016/j.ejrad.2010.12.103
• 141 ten Kate G L, Sijbrands E J, Staub D et al. Noninvasive imaging of the vulnerable atherosclerotic plaque.  Curr Probl Cardiol. 2010;  35 556-591
• 142 Clevert D A, Sommer W H, Helck A et al. Duplex and contrast enhanced ultrasound (CEUS) in evaluation of in-stent restenosis after carotid stenting.  Clin Hemorheol Microcirc. 2011;  in press
• 143 Massalha K, Goyen M, Rudofsky G. Stenosis-jet can cause a dissection of the superficial femoral artery.  Vasa. 1999;  28 131-133
• 144 Koennecke H C, Trocio S H, Mast Jr. H et al. Microemboli on transcranial Doppler in patients with spontaneous carotid artery dissection.  J Neuroimaging. 1997;  7 217-220
• 145 Clevert D A, Kubisch C, Meimarakis G et al. Improved visualization of carotid-jugular arteriovenous fistula by contrast-enhanced ultrasound.  Ultraschall in Med. 2010;  31 610-612
• 146 Jaff M R, Goldmakher G V, Lev M H et al. Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography.  Vasc Med. 2008;  13 281-292
• 147 Coli S, Magnoni M, Sangiorgi G et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity.  J Am Coll Cardiol. 2008;  52 223-230
• 148 Giannoni M F, Vicenzini E, Citone M et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study.  Eur J Vasc Endovasc Surg. 2009;  37 722-727
• 149 Staub D, Schinkel A F, Coll B et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques.  JACC Cardiovasc Imaging. 2010;  3 761-771
• 150 Staub D, Patel M B, Tibrewala A et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events.  Stroke. 2010;  41 41-47
• 151 Catalano O, Lobianco R, Cusati B et al. Contrast-enhanced sonography for diagnosis of ruptured abdominal aortic aneurysm.  Am J Roentgenol. 2005;  184 423-427
• 152 Spittell P C, Spittell J A, Joyce J W et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990).  Mayo Clin Proc. 1993;  68 642-651
• 153 Clevert D A, Rupp Jr. N, Reiser M et al. Improved diagnosis of vascular dissection by ultrasound B-flow: a comparison with color-coded Doppler and power Doppler sonography.  Eur Radiol. 2005;  15 342-347
• 154 Clevert D A, Stickel M, Johnson T et al. Imaging of aortic abnormalities with contrast-enhanced ultrasound. A pictorial comparison with CT.  Eur Radiol. 2007;  17 2991-3000
• 155 Clevert D A, Stickel M, Kopp R et al. Contrast-enhanced ultrasound versus CT and operative findings in evaluation of renal vein aneurysm with AV fistula.  Clin Hemorheol Microcirc. 2008;  39 147-154
• 156 Arrive L, Correas J M, Leseche G et al. Inflammatory aneurysms of the abdominal aorta: CT findings.  Am J Roentgenol. 1995;  165 1481-1484
• 157 Pennell R C, Hollier L H, Lie J T et al. Inflammatory abdominal aortic aneurysms: a thirty-year review.  J Vasc Surg. 1985;  2 859-869
• 158 Walker D I, Bloor K, Williams G et al. Inflammatory aneurysms of the abdominal aorta.  Br J Surg. 1972;  59 609-614
• 159 Witz M, Korzets Z. Inflammatory abdominal aortic aneurysms.  Isr Med Assoc J. 2005;  7 385-387
• 160 Crawford J L, Stowe C L, Safi H J et al. Inflammatory aneurysms of the aorta.  J Vasc Surg. 1985;  2 113-124
• 161 Clevert D A, Schick K, Chen M H et al. Role of contrast enhanced ultrasound in detection of abdominal aortic abnormalities in comparison with multislice computed tomography.  Chin Med J (Engl). 2009;  122 858-864
• 162 Thurnher S, Cejna M. Imaging of aortic stent-grafts and endoleaks.  Radiol Clin North Am. 2002;  40 799-833
• 163 Clevert D A, Minaifar N, Weckbach S et al. Color duplex ultrasound and contrast-enhanced ultrasound in comparison to MS-CT in the detection of endoleak following endovascular aneurysm repair.  Clin Hemorheol Microcirc. 2008;  39 121-132
• 164 d’Audiffret A, Desgranges P, Kobeiter D H et al. Follow-up evaluation of endoluminally treated abdominal aortic aneurysms with duplex ultrasonography: validation with computed tomography.  J Vasc Surg. 2001;  33 42-50
• 165 Sommer W H, Hoffmann R T, Becker C R et al. Comparison of time-resolved CT-angiography, contrast-enhanced ultrasound and digital subtraction angiography in a patient with a small type II endoleak after endovascular aneurysm repair.  Clin Hemorheol Microcirc. 2010;  45 19-25
• 166 McLafferty R B, McCrary B S, Mattos M A et al. The use of color-flow duplex scan for the detection of endoleaks.  J Vasc Surg. 2002;  36 100-104
• 167 Greenfield A L, Halpern E J, Bonn J et al. Application of duplex US for characterization of endoleaks in abdominal aortic stent-grafts: report of five cases.  Radiology. 2002;  225 845-851
• 168 Jung E M, Rennert J, Fellner C et al. Detection and characterization of endoleaks following endovascular treatment of abdominal aortic aneurysms using contrast harmonic imaging (CHI) with quantitative perfusion analysis (TIC) compared to CT angiography (CTA).  Ultraschall in Med. 2010;  31 564-570
• 169 Pfister K, Rennert J, Uller W et al. Contrast harmonic imaging ultrasound and perfusion imaging for surveillance after endovascular abdominal aneurysm repair regarding detection and characterization of suspected endoleaks.  Clin Hemorheol Microcirc. 2009;  43 119-128
• 170 Ten Bosch J A, Rouwet E V, Peters C T et al. Contrast-enhanced ultrasound versus computed tomographic angiography for surveillance of endovascular abdominal aortic aneurysm repair.  J Vasc Interv Radiol. 2010;  21 638-643
• 171 Seidel G, Meairs S. Ultrasound contrast agents in ischemic stroke.  Cerebrovasc Dis. 2009;  27 (Suppl 2) 25-39
• 172 Seidel G, Kaps M. Harmonic imaging of the vertebrobasilar system.  Stroke. 1997;  28 1610-1613
• 173 Postert T, Braun B, Meves S et al. Contrast-enhanced transcranial color-coded sonography in acute hemispheric brain infarction.  Stroke. 1999;  30 1819-1826
• 174 Droste D W, Jurgens R, Weber S et al. Benefit of echocontrast-enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways.  Stroke. 2000;  31 920-923
• 175 Seidel G, Cangur H, Meyer-Wiethe K et al. On the ability of ultrasound parametric perfusion imaging to predict the area of infarction in acute ischemic stroke.  Ultraschall in Med. 2006;  27 543-548
• 176 Eyding J, Krogias C, Schollhammer M et al. Contrast-enhanced ultrasonic parametric perfusion imaging detects dysfunctional tissue at risk in acute MCA stroke.  J Cereb Blood Flow Metab. 2006;  26 576-582
• 177 Krogias C, Hennebohl C, Geier B et al. Transcranial ultrasound perfusion imaging and perfusion-MRI – a pilot study on the evaluation of cerebral perfusion in severe carotid artery stenosis.  Ultrasound Med Biol. 2010;  36 1973-1980
• 178 Krogias C, Meves S H, Hansen C et al. Ultrasound Perfusion Imaging of the Brain-Routine and Novel Applications: Uncommon Cases and Review of the Literature.  J Neuroimaging. 2010;  21 255-258
• 179 Eggers J, Konig I R, Koch B et al. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study.  Stroke. 2008;  39 1470-1475
• 180 FitzGerald O, Bresnihan B. Synovial membrane cellularity and vascularity.  Ann Rheum Dis. 1995;  54 511-515
• 181 Klauser A, Frauscher F, Schirmer M. Value of contrast-enhanced power Doppler ultrasonography (US) of the metacarpophalangeal joints on rheumatoid arthritis.  Eur Radiol. 2004;  14 545-546, author reply 547 – 548
• 182 Klauser A S, Peetrons P. Developments in musculoskeletal ultrasound and clinical applications.  Skeletal Radiol. 2010;  39 1061-1071
• 183 De Zordo T, Mlekusch S P, Feuchtner G M et al. Value of contrast-enhanced ultrasound in rheumatoid arthritis.  Eur J Radiol. 2007;  64 222-230
• 184 Taylor P C. The value of sensitive imaging modalities in rheumatoid arthritis.  Arthritis Res Ther. 2003;  5 210-213
• 185 Hermann K G, Backhaus M, Schneider U et al. Rheumatoid arthritis of the shoulder joint: comparison of conventional radiography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging.  Arthritis Rheum. 2003;  48 3338-3349
• 186 Klauser A, Frauscher F, Schirmer M et al. The value of contrast-enhanced color Doppler ultrasound in the detection of vascularization of finger joints in patients with rheumatoid arthritis.  Arthritis Rheum. 2002;  46 647-653
• 187 Doria A S, Kiss M H, Lotito A P et al. Juvenile rheumatoid arthritis of the knee: evaluation with contrast-enhanced color Doppler ultrasound.  Pediatr Radiol. 2001;  31 524-531
• 188 Magarelli N, Guglielmi G, Di Matteo L et al. Diagnostic utility of an echo-contrast agent in patients with synovitis using power Doppler ultrasound: a preliminary study with comparison to contrast-enhanced MRI.  Eur Radiol. 2001;  11 1039-1046
• 189 Klauser A, Halpern E J, Frauscher F et al. Inflammatory low back pain: high negative predictive value of contrast-enhanced color Doppler ultrasound in the detection of inflamed sacroiliac joints.  Arthritis Rheum. 2005;  53 440-444
• 190 Ostergaard M, Hansen M, Stoltenberg M et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis.  Arthritis Rheum. 1999;  42 918-929
• 191 Klauser A, Demharter J, De Marchi A et al. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group.  Eur Radiol. 2005;  15 2404-2410
• 192 Schueller-Weidekamm C, Krestan C, Schueller G et al. Power Doppler sonography and pulse-inversion harmonic imaging in evaluation of rheumatoid arthritis synovitis.  Am J Roentgenol. 2007;  188 504-508
• 193 Klauser A S, Franz M, Arora R et al. Detection of vascularity in wrist tenosynovitis: power doppler ultrasound compared with contrast-enhanced grey-scale ultrasound.  Arthritis Res Ther. 2010;  12 R209
• 194 Wamser G, Bohndorf K, Vollert K et al. Power Doppler sonography with and without echo-enhancing contrast agent and contrast-enhanced MRI for the evaluation of rheumatoid arthritis of the shoulder joint: differentiation between synovitis and joint effusion.  Skeletal Radiol. 2003;  32 351-359
• 195 Carotti M, Salaffi F, Manganelli P et al. Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience.  Ann Rheum Dis. 2002;  61 877-882
• 196 Hau M, Kneitz C, Tony H P et al. High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor alpha receptor (etanercept).  Ann Rheum Dis. 2002;  61 55-58
• 197 Song I H, Althoff C E, Hermann K G et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI.  Ann Rheum Dis. 2009;  68 75-83
• 198 Qvistgaard E, Kristoffersen H, Terslev L et al. Guidance by ultrasound of intra-articular injections in the knee and hip joints.  Osteoarthritis Cartilage. 2001;  9 512-517
• 199 Qvistgaard E, Rogind H, Torp-Pedersen S et al. Quantitative ultrasonography in rheumatoid arthritis: evaluation of inflammation by Doppler technique.  Ann Rheum Dis. 2001;  60 690-693
• 200 Lanzani C, Savasi V, Leone F P et al. Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program.  Fertil Steril. 2009;  92 1158-1161
• 201 Boudghene F P, Bazot M, Robert Y et al. Assessment of Fallopian tube patency by HyCoSy: comparison of a positive contrast agent with saline solution.  Ultrasound Obstet Gynecol. 2001;  18 525-530
• 202 Tamasi F, Weidner A, Domokos N et al. ECHOVIST-200 enhanced hystero-sonography: a new technique in the assessment of infertility.  Eur J Obstet Gynecol Reprod Biol. 2005;  121 186-190
• 203 Foschi F G, Piscaglia F, Pompili M et al. Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax.  Ultraschall in Med. 2008;  29 538-542
• 204 Tamano M, Hashimoto T, Kojima K et al. Diagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of Sonazoid.  J Gastroenterol Hepatol. 2010;  25 383-386
• 205 Ignee A, Baum U, Schuessler G et al. Contrast-enhanced ultrasound-guided percutaneous cholangiography and cholangiodrainage (CEUS-PTCD).  Endoscopy. 2009;  41 725-726
• 206 Mao R, Xu E J, Li K et al. Usefulness of contrast-enhanced ultrasound in the diagnosis of biliary leakage following T-tube removal.  J Clin Ultrasound. 2009;  38 38-40
• 207 Zuber-Jerger I, Endlicher E, Scholmerich J et al. Endoscopic retrograde cholangiography with contrast ultrasonography.  Endoscopy. 2008;  40 (Suppl 2) E202
• 208 Zengel P, Berghaus A, Weiler C et al. Intraductally applied contrast-enhanced ultrasound (IA-CEUS) for evaluating obstructive disease and secretory dysfunction of the salivary glands.  Eur Radiol. 2011;  21 1339-1348
• 209 Volkmer B G, Nesslauer T, Kufer R et al. [Diagnosis of vesico-intestinal fistulas by contrast medium enhanced 3-D ultrasound].  Ultraschall in Med. 2001;  22 81-86
• 210 Chew S S, Yang J L, Newstead G L et al. Anal fistula: Levovist-enhanced endoanal ultrasound: a pilot study.  Dis Colon Rectum. 2003;  46 377-384
• 211 Moritz J D, Ludwig A, Oestmann J W. Contrast-enhanced color Doppler sonography for evaluation of enlarged cervical lymph nodes in head and neck tumors.  Am J Roentgenol. 2000;  174 1279-1284
• 212 Benzel W, Zenk J, Winter M et al. [Color Doppler ultrasound studies of benign and malignant lymph nodes].  HNO. 1996;  44 666-671
• 213 Schmid-Wendtner M H, Partscht K, Korting H C et al. Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography.  Arch Dermatol. 2002;  138 491-497
• 214 Schulte-Altedorneburg G, Demharter J, Linne R et al. Does ultrasound contrast agent improve the diagnostic value of colour and power Doppler sonography in superficial lymph node enlargement?.  Eur J Radiol. 2003;  48 252-257
• 215 Schmid-Wendtner M H, Dill-Muller D, Baumert J et al. Lymph node metastases in patients with cutaneous melanoma: improvements in diagnosis by signal-enhanced color Doppler sonography.  Melanoma Res. 2004;  14 269-276
• 216 Zenk J, Bozzato A, Steinhart H et al. Metastatic and inflammatory cervical lymph nodes as analyzed by contrast-enhanced color-coded Doppler ultrasonography: quantitative dynamic perfusion patterns and histopathologic correlation.  Ann Otol Rhinol Laryngol. 2005;  114 43-47
• 217 Stoeckelhuber B M, Wiesmann M, Berg S A et al. [Sonography of enlarged lymph nodes: Pathogenetic categorization using contrast enhanced power Doppler sonography].  Hautarzt. 2006;  57 610-617
• 218 Weskott H P. Emerging roles for contrast-enhanced ultrasound.  Clin Hemorheol Microcirc. 2008;  40 51-71
• 219 Steppan I, Reimer D, Muller-Holzner E et al. Breast cancer in women: evaluation of benign and malignant axillary lymph nodes with contrast-enhanced ultrasound.  Ultraschall in Med. 2010;  31 63-67
• 220 Ouyang Q, Chen L, Zhao H et al. Detecting metastasis of lymph nodes and predicting aggressiveness in patients with breast carcinomas.  J Ultrasound Med. 2010;  29 343-352
• 221 Stramare R, Scagliori E, Mannucci M et al. The role of contrast-enhanced gray-scale ultrasonography in the differential diagnosis of superficial lymph nodes.  Ultrasound Q. 2010;  26 45-51
• 222 Yu M, Liu Q, Song H P et al. Clinical application of contrast-enhanced ultrasonography in diagnosis of superficial lymphadenopathy.  J Ultrasound Med. 2010;  29 735-740
• 223 Rubaltelli L, Beltrame V, Tregnaghi A et al. Contrast-enhanced ultrasound for characterizing lymph nodes with focal cortical thickening in patients with cutaneous melanoma.  Am J Roentgenol. 2011;  196 W8-W12
• 224 Hocke M, Menges M, Topalidis T et al. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes.  J Cancer Res Clin Oncol. 2008;  134 473-480
• 225 Nakase K, Yamamoto K, Hiasa A et al. Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma.  Cancer Detect Prev. 2006;  30 188-191
• 226 Rue Nielsen K, Klyver H, Hougaard Chakera A et al. Sentinel node detection in melanomas using contrast-enhanced ultrasound.  Acta Radiol. 2009;  50 412-417
• 227 Wang Y, Wang W, Li J et al. Gray-scale contrast-enhanced ultrasonography of sentinel lymph nodes in a metastatic breast cancer model.  Acad Radiol. 2009;  16 957-962
• 228 Omoto K, Matsunaga H, Take N et al. Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study.  Ultrasound Med Biol. 2009;  35 1249-1256
• 229 Sever A, Jones S, Cox K et al. Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer.  Br J Surg. 2009;  96 1295-1299
• 230 Nielsen K R. Studies on radionuclide imaging and contrast ultrasound for sentinel node diagnostics in breast cancer and melanoma.  Dan Med Bull. 2011;  58 B4225
• 231 Sever A R, Mills P, Jones S E et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer.  Am J Roentgenol. 2010;  196 251-256
• 232 Tozer G M. Measuring tumour vascular response to antivascular and antiangiogenic drugs.  Br J Radiol. 2003;  76 Spec No 1 S23-S35
• 233 Eisenhauer E A, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).  Eur J Cancer. 2009;  45 228-247
• 234 Zhu A X, Holalkere N S, Muzikansky A et al. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.  Oncologist. 2008;  13 120-125
• 235 Peronneau P, Lassau N, Leguerney I et al. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.  Ultraschall in Med. 2010;  31 370-378
• 236 Averkiou M, Lampaskis M, Kyriakopoulou K et al. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy.  Ultrasound Med Biol. 2010;  36 68-77
• 237 Williams R, Hudson J M, Lloyd B A et al. Dynamic Microbubble Contrast-enhanced US to Measure Tumor Response to Targeted Therapy: A Proposed Clinical Protocol with Results from Renal Cell Carcinoma Patients Receiving Antiangiogenic Therapy.  Radiology. 2011;  260 581-590
• 238 Lassau N, Lamuraglia M, Vanel D et al. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases.  Ann Oncol. 2005;  16 1054-1060
• 239 Cosgrove D, Lassau N. Imaging of perfusion using ultrasound.  Eur J Nucl Med Mol Imaging. 2010;  37 (Suppl 1) S65-S85
• 240 Lamuraglia M, Escudier B, Chami L et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound.  Eur J Cancer. 2006;  42 2472-2479
• 241 Lassau N, Lamuraglia M, Chami L et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography.  Am J Roentgenol. 2006;  187 1267-1273
• 242 De Giorgi U, Aliberti C, Benea G et al. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.  Clin Cancer Res. 2005;  11 6171-6176
• 243 Escudier B, Lassau N, Angevin E et al. Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma.  Clin Cancer Res. 2007;  13 1801-1809
• 244 Lassau N, Koscielny S, Albiges L et al. Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography.  Clin Cancer Res. 2010;  16 1216-1225
• 245 Lassau N, Chami L, Koscielny S et al. Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib.  Invest New Drugs. 2010;  epub DOI: 10.1007/s10637-010-9592-2
• 246 Lassau N, Koscielny S, Chami L et al. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification – preliminary results.  Radiology. 2011;  258 291-300
• 247 Lassau N, Chami L, Chebil M et al. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments.  Discov Med. 2011;  11 18-24
• 248 Casali P G, Blay J Y. Experts ECECPo . Gastrointestinal stromal tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.  Ann Oncol. 2010;  (Suppl 5) v98-v102
• 249 Cosgrove D O, Bamber J C, Davey J B et al. Color Doppler signals from breast tumors. Work in progress.  Radiology. 1990;  176 175-180
• 250 Sorelli P G, Cosgrove D O, Svensson W E et al. Can contrast-enhanced sonography distinguish benign from malignant breast masses?.  J Clin Ultrasound. 2010;  38 177-181
• 251 Balleyguier C, Opolon P, Mathieu M C et al. New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature.  Eur J Radiol. 2009;  69 14-23
• 252 Liu H, Jiang Y X, Liu J B et al. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations.  Breast. 2008;  17 532-539
• 253 Caproni N, Marchisio F, Pecchi A et al. Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI.  Eur Radiol. 2009;  20 1384-1395
• 254 Friedrich-Rust M, Glasemann T, Polta A et al. Differentiation between Benign and Malignant Adrenal Mass using Contrast-Enhanced Ultrasound.  Ultraschall in Med. 2011;  epub DOI: 10.1055/s-0031-1273408
• 255 Dietrich C F, Ignee A, Barreiros A P et al. Contrast-enhanced ultrasound for imaging of adrenal masses.  Ultraschall in Med. 2010;  31 163-168
• 256 Testa A C, Ferrandina G, Fruscella E et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study.  J Ultrasound Med. 2005;  24 1267-1278
• 257 Lieng M, Qvigstad E, Dahl G F et al. Flow differences between endometrial polyps and cancer: a prospective study using intravenous contrast-enhanced transvaginal color flow Doppler and three-dimensional power Doppler ultrasound.  Ultrasound Obstet Gynecol. 2008;  32 935-940
• 258 Marret H, Sauget S, Giraudeau B et al. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.  J Ultrasound Med. 2004;  23 1629-1639, quiz 1641 – 1642
• 259 Orden M R, Jurvelin J S, Kirkinen P P. Kinetics of a US contrast agent in benign and malignant adnexal tumors.  Radiology. 2003;  226 405-410
• 260 Testa A C, Timmerman D, Exacoustos C et al. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.  Ultrasound Obstet Gynecol. 2007;  29 512-516
• 261 Caruso G, Salvaggio G, Campisi A et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound.  Am J Roentgenol. 2010;  194 151-156
• 262 Drudi F M, Cantisani V, Liberatore M et al. Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study.  Ultraschall in Med. 2010;  31 589-595
• 263 Nicolau C, Bunesch L, Sebastia C et al. Diagnosis of bladder cancer: contrast-enhanced ultrasound.  Abdom Imaging. 2010;  35 494-503
• 264 Lefevre F, Correas J M, Briancon S et al. Contrast-enhanced sonography of the renal transplant using triggered pulse-inversion imaging: preliminary results.  Ultrasound Med Biol. 2002;  28 303-314
• 265 Mitterberger M J, Aigner F, Horninger W et al. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.  Eur Radiol. 2010;  20 2791-2796
• 266 Wink M, Frauscher F, Cosgrove D et al. Contrast-enhanced ultrasound and prostate cancer, a multicentre European research coordination project.  Eur Urol. 2008;  54 982-992
• 267 Aigner F, Pallwein L, Mitterberger M et al. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate.  BJU Int. 2009;  103 458-463
• 268 Sano F, Terao H, Kawahara T et al. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer.  BJU Int. 2010;  107 1404-1410
• 269 Strazdina A, Krumina G, Sperga M. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer.  Anticancer Res. 2011;  31 1421-1426
• 270 Davis P M, Gloviczki P, Cherry K J et al. Aorto-caval and ilio-iliac arteriovenous fistulae.  Am J Surg. 1998;  176 115-118
• 271 Gardiner M D, Nanchahal Jr J. Strategies to ensure success of microvascular free tissue transfer.  J Plast Reconstr Aesthet Surg. 2010;  63 e665-673
• 272 Prantl L, Pfister K, Kubale R et al. Value of high resolution ultrasound and contrast enhanced US pulse inversion imaging for the evaluation of the vascular integrity of free-flap grafts.  Clin Hemorheol Microcirc. 2007;  36 203-216
• 273 Prantl L, Schmitt S, Geis S et al. Contrast harmonic ultrasound and indocyanine-green fluorescence video angiography for evaluation of dermal and subdermal microcirculation in free parascapular flaps.  Clin Hemorheol Microcirc. 2008;  38 105-118
• 274 Prantl L, Schreml S, Walter M et al. Evaluation of microcirculation of free flaps of the lower leg by contrast harmonic imaging (CHI) with time intensity curve (TIC) analysis.  Clin Hemorheol Microcirc. 2008;  39 343-350
• 275 Lamby P, Prantl L, Schreml S et al. Improvements in high resolution ultrasound for postoperative investigation of capillary microperfusion after free tissue transfer.  Clin Hemorheol Microcirc. 2009;  43 35-49
• 276 Prantl L, Fellner C, Jung M E. Evaluation of free flap perfusion with dynamic contrast-enhanced magnetic resonance imaging.  Plast Reconstr Surg. 2010;  126 100e-101e
• 277 Jung E M, Prantl L, Schreyer A G et al. New perfusion imaging of tissue transplants with Contrast Harmonic Ultrasound Imaging (CHI) and Magnetic Resonance Imaging (MRI) in comparison with laser-induced Indocyanine Green (ICG) fluorescence angiography.  Clin Hemorheol Microcirc. 2009;  43 19-33
• 278 Geis S, Prantl L, Gehmert S et al. TTP (time to PEAK) and RBV (regional blood volume) as valuable parameters to detect early flap failure.  Clin Hemorheol Microcirc. 2011;  47 1-14
• 279 Fellner C, Jung E M, Prantl L. Dynamic contrast-enhanced MRI as a valuable non-invasive tool to evaluate tissue perfusion of free flaps: Preliminary results.  Clin Hemorheol Microcirc. 2010;  46 77-87
• 280 Lamby P, Prantl L, Fellner C et al. Post-operative monitoring of tissue transfers: Advantages using contrast enhanced ultrasound (CEUS) and contrast enhanced MRI (ceMRI) with dynamic perfusion analysis?.  Clin Hemorheol Microcirc. 2011;  in press
• 281 ESUR guidelines on contrast media. http://wwwesurorg/Contrast-media510html#c270 [accessed June 2011]
• 282 Thomsen H S. ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis.  Eur Radiol. 2007;  17 2692-2696